H.Res. 309 — Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.